LAFAYETTE, La., (June 9, 2025) -- Viemed Healthcare Inc. has announced the authorization of a share repurchase program by its Board of Directors, effective through June 2026. The program allows for the repurchase of up to 1,976,441 common shares, representing approximately 5% of the total issued and outstanding shares as of March 31, 2025. Share repurchases will be conducted through open market or block purchases in compliance with securities laws. The market price at the time of purchase, plus applicable brokerage fees, will determine the repurchase price. The company retains the right to discontinue purchases at any time, with all repurchased shares set to be cancelled.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.